AIM ImmunoTech Inc (AIM)
0.2101
0.00 (0.00%)
USD |
NYAM |
Nov 22, 16:00
0.21
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech Cash from Investing (Quarterly): 0.334M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.334M |
| June 30, 2024 | 0.826M |
| March 31, 2024 | -0.158M |
| December 31, 2023 | -0.214M |
| September 30, 2023 | -0.336M |
| June 30, 2023 | -0.204M |
| March 31, 2023 | -0.078M |
| December 31, 2022 | 3.363M |
| September 30, 2022 | 0.25M |
| June 30, 2022 | 7.721M |
| March 31, 2022 | -0.346M |
| December 31, 2021 | 0.364M |
| September 30, 2021 | -0.366M |
| June 30, 2021 | -1.152M |
| March 31, 2021 | 0.523M |
| December 31, 2020 | -0.182M |
| September 30, 2020 | -9.583M |
| June 30, 2020 | -3.082M |
| March 31, 2020 | 3.683M |
| December 31, 2019 | -5.289M |
| September 30, 2019 | -0.232M |
| June 30, 2019 | 0.472M |
| March 31, 2019 | -1.098M |
| December 31, 2018 | -1.518M |
| September 30, 2018 | 0.617M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.043M |
| March 31, 2018 | 1.036M |
| December 31, 2017 | 1.087M |
| September 30, 2017 | 0.16M |
| June 30, 2017 | 0.997M |
| March 31, 2017 | 0.486M |
| December 31, 2016 | -0.027M |
| September 30, 2016 | 1.39M |
| June 30, 2016 | 1.613M |
| March 31, 2016 | -0.06M |
| December 31, 2015 | 4.269M |
| September 30, 2015 | 2.438M |
| June 30, 2015 | -0.163M |
| March 31, 2015 | -0.192M |
| December 31, 2014 | 1.881M |
| September 30, 2014 | 1.071M |
| June 30, 2014 | -0.243M |
| March 31, 2014 | -0.177M |
| December 31, 2013 | 9.271M |
| September 30, 2013 | 4.316M |
| June 30, 2013 | 3.512M |
| March 31, 2013 | 5.24M |
| December 31, 2012 | -11.00M |
| September 30, 2012 | -6.993M |
| June 30, 2012 | 0.287M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-9.583M
Minimum
Sep 2020
7.721M
Maximum
Jun 2022
-0.1963M
Average
-0.17M
Median
Cash from Investing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -29.74M |
| Protalix BioTherapeutics Inc | 20.33M |
| Electromed Inc | -0.058M |
| Xtant Medical Holdings Inc | -2.009M |
| Armata Pharmaceuticals Inc | -0.34M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.11M |
| Cash from Financing (Quarterly) | 0.137M |
| Free Cash Flow | -21.33M |
| Free Cash Flow Per Share (Quarterly) | -0.0567 |
| Free Cash Flow to Equity (Quarterly) | -3.363M |
| Free Cash Flow Yield | -194.4% |